Hedge Fund - RA Capital Management
Jade Biosciences Inc. (JBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $23,072,151 | 0.39% | 262,631.2 | $87.82 |
| 2 | 2024 - Q4 (2024-12-31) | $24,359,044 | 0.32% | 262,631.2 | $86.18 |
| 3 | 2024 - Q3 (2024-09-30) | $19,211,472 | 0.22% | 262,631.2 | $64.50 |
| 4 | 2024 - Q2 (2024-06-30) | $15,258,873 | 0.2% | 262,631.2 | $663.24 |
| 5 | 2024 - Q1 (2024-03-31) | $244,365,948 | 3.1% | 236,113.77,142,857 | $763.79 |
| 6 | 2023 - Q4 (2023-12-31) | $187,013,913 | 2.92% | 236,113.77,142,857 | $509.56 |
| 7 | 2023 - Q3 (2023-09-30) | $112,142,236 | 2.2% | 236,113.77,142,857 | $541.63 |
| 8 | 2023 - Q2 (2023-06-30) | $141,727,291 | 2.67% | 236,113.77,142,857 | $639.61 |
| 9 | 2023 - Q1 (2023-03-31) | $166,684,517 | 3.77% | 236,113.77,142,857 | $829.37 |
| 10 | 2022 - Q4 (2022-12-31) | $242,134,673 | 4.91% | 236,113.77,142,857 | $725.99 |
| 11 | 2022 - Q3 (2022-09-30) | $137,017,000 | 2.92% | 236,113.77,142,857 | $667.58 |
| 12 | 2022 - Q2 (2022-06-30) | $129,166,000 | 3.44% | 236,113.77,142,857 | $477.56 |
| 13 | 2022 - Q1 (2022-03-31) | $151,479,000 | 3.3% | 236,113.77,142,857 | $388.12 |
| 14 | 2021 - Q4 (2021-12-31) | $97,432,000 | 1.71% | 236,113.77,142,857 | $505.82 |
| 15 | 2021 - Q3 (2021-09-30) | $173,378,000 | 2.4% | 236,113.77,142,857 | $559.81 |
| 16 | 2021 - Q2 (2021-06-30) | $188,667,000 | 3.02% | 236,113.77,142,857 | $799.05 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:35.0000 on 2025-04-29